Skip to content
★ Sign in to follow
DL

David L. Berstein

Executive
Ariad Pharmaceuticals Inc
Total declarations
91
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (43 ops.)
€4.4M

Latest filing published 22 Mar 2016 for ARIAD PHARMACEUTICALS INC.

Insider track record

Disclosed buys
0
Disclosed sells
43
Signal history

David L. Berstein: trading record in brief

David L. Berstein discloses dealings in Ariad Pharmaceuticals Inc to SEC (Form 4). We count 91 filings; the first trade dates from 12 October 2008 and the latest from 21 March 2016.

Every open-market trade on record is a sale: 43 sales worth €4.4M. Besides market trades, the filings include 8 share grants and 40 option exercises. 2016 to date brings no purchases and 3 sales.

The record was last updated on 22 March 2016 with an option exercise in Ariad Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to David L. Berstein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations79 total

25 of 79 declarations